Haff disease laboratory findings

Haff disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Haff disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Haff disease laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Haff disease laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Haff disease laboratory findings
CDC on Haff disease laboratory findings
Haff disease laboratory findings in the news
Blogs on Haff disease laboratory findings
Directions to Hospitals Treating Haff disease
Risk calculators and risk factors for Haff disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S

Laboratory findings

Since Haff disease causes rhabdomyolysis, the approach to the evaluation of rhabdomyolysis should be as follows:

• CBC (complete blood count)
• Creatine kinase (three-five times the upper limit of normal values of 100 to 400 IU/L)
• Chemistries (hyperkalemia, hyperphosphatemia, and hypocalcemia)
• Liver function test
• Urine pH
• Urinalysis
  • Blood (+)
  • No red blood cells on microscopy (seen in either hemoglobinuria or myoglobinuria)